SOURCE: American Diabetes Association, news release, June 23, 2025 Copyright 2025 HealthDay
Alternatives and Backup Options in PlexusDx Medication Portfolio PlexusDx offers multiple GLP-1 options beyond compounded semaglutide injection, reducing reliance on any single product
Ashley Koff, RD 00:33:02 I mean, I think what we are now starting to understand is just the global nature of GLP one in particular, a little bit less with GIP, but still significant in terms of receptor sites throughout the body and the impact there
These can include oral devices, nerve stimulators, surgical correction, lifestyle changes, positional aids, and in some cases, medication